FOYA Program

Off
Takeda’s beePFS project is a testament to the company’s commitment to innovation, adaptability, and excellence in project execution. By achieving remarkable success within an accelerated timeline, Takeda has demonstrated...
Off
The facility is designed to be resilient and independent from the electrical grid in times of power outage or emergency. The microgrid allows the facility to operate in "island mode" and use the battery backup system to...
Off
The Zydus OSD project focused on process innovation and automation to scale up, reducing costs and turn-around times. It is for those reasons it has been recognized with an Honorable Mention for the 2024 ISPE FOYA...
Off
UK4 is a biological drug substance manufacturing facility that was designed and built under a “Three Zeros for Sustainable Development” concept. The three zeros encompass: 1) zero halogenated hydrocarbons, 2) zero...
Media & Press Releases
12 August 2024
Takeda has been recognized as a 2024 ISPE Facility of the Year Awards (FOYA) category winner in the Operations – Facility Fit. In this Q&A interview, Outsourced Pharma discusses Takeda’s successful beePFS project with Roland Fabris, Managing Director...
Media & Press Releases
01 August 2024
Eli Lilly has been recognized as a 2024 ISPE Facility of the Year Awards (FOYA) – Innovation category winner. In this Q&A interview, Pharmaceutical Online discusses Eli Lilly and Company’s approach to high-throughput peptide manufacturing with Matt...
Media & Press Releases
27 June 2024
Chugai Pharma Manufacturing Co., Ltd. has been recognized as a 2024 ISPE Facilities of the Year Award (FOYA) – Social Impact category winner. In this Q&A interview, Bioprocess Online discusses Chugai’s innovative approach to achieving zero emissions...